This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (38)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ARTHUR L. CHANDLER, M.D.; MORTIMER A. HARTMAN, M.D.

AMA Arch Gen Psychiatry 1960;2(3):286-299.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Our use of drug-facilitated psychotherapy has been to aid repressed material to become conscious and to increase insight. Any method or tool which facilitates these processes has the possibility of being a valuable psychotherapeutic tool. Certain drugs on which we have done research, such as mescaline, ALD-52, ibogaine, psilocybin, Ditran (N-ethyl-3-piperidyl cyclopentylphenyl glycolate HC1), and lysergic acid diethylamide (LSD-25), have the capacity to broaden the patient’s spectrum of awareness. If a patient uses this enhanced capacity to look inward, he is often enabled, particularly in the case of LSD-25, to see and experience many affects, childhood memories, conflicts, and impulse strivings which were previously blotted out by the repressive forces.

The present study was conducted in an attempt further to evaluate the use of LSD-25 as an aid to psychotherapy and to develop procedures and techniques for its most effective utilization with . . . [Full Text PDF of this Article]

Author Affiliations
Beverly Hills, Calif.

Footnotes
Submitted for publication Aug. 18, 1959.

ALD-52, psilocybin, and LSD-25 were supplied by Sandoz Pharmaceuticals.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?